Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis-C virus cirrhosisFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 31 January 2014

References

• M.A.GomesD.G.PriolliJ.G.TralhãoM.F.BotelhoHepatocellular carcinoma: epidemiology, biology, diagnosis, and therapiesRev Assoc Med Bras5952013514524
   PubMed Web of Science ®Google Scholar
• N.MokhtarI.GoudaI.AdelCancer Pathology Registry: 2003–2004, and Time Trend Analysis2007National Cancer InstituteCairo University
   Google Scholar
• Di Bisceglie AM. In: Friedman LS, Keeffe EB., (Eds.) Handbook of Liver Disease. 2nd ed. Philadelphia: Elsevier/Saunders; 2004, pp. 339–48.
   Google Scholar
• J.M.LlovetA.BurroughsI.BruixHepatocellular carcinomaLancet362200319071917
   PubMed Web of Science ®Google Scholar
• X.Y.WangF.DegosS.DuboisS.TessioreM.AllegrettaR.D.GuttmannGlypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomasHuman Pathol37200614351441
   PubMed Web of Science ®Google Scholar
• M.F.YuenC.L.LaiSerological markers of liver cancerBest Pract Res Clin Gastroenterol1920059199
   PubMed Web of Science ®Google Scholar
• J.FilmusM.CapurroGlypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinomaMol Diagn842004207212
   PubMedGoogle Scholar
• B.H.ZhangB.H.YangZ.Y.TangRandomized controlled trial of screening for hepatocellular carcinomaJ Cancer Res Clin Oncol1302004417422
   PubMed Web of Science ®Google Scholar
• B.DanieleA.BencivengaA.S.MegnaV.TinessaAlpha-fetoprotein and ultrasonography screening for hepatocellular carcinomaGastroenterology132004 S108–S12
   Google Scholar
• O.M.SoyemiJ.A.OtegbayoS.O.OlaA.AkereT.SoyemiComparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinomaBMC Res Notes52012403
   PubMedGoogle Scholar
• N.T.ZinkinF.GrallK.BhaskarH.H.OtuD.SpentzosB.KalmowitzSerum proteomics and biomarkers in hepatocellular carcinoma and chronic liver diseaseClin Cancer Res142008470477
   PubMed Web of Science ®Google Scholar
• HuiLiuPengLiYunZhaiQuChun-FengLi-JieZhangYu-FenTanDiagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinomaWorld J Gastroenterol1635201044104415
   Web of Science ®Google Scholar
• H.L.WangF.AnatelliQ.J.ZhaiB.AdleyS.T.ChuangX.J.YangGlypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesionsArch Pathol Lab Med13211200817231728
   Web of Science ®Google Scholar
• A.R.El-ZayadiH.M.BadranE.M.F.BarakatM.E.AttiaS.ShawkyM.K.MohamedHepatocellular carcinoma in Egypt: a single center study over a decadeWorld J Gastroenterol1133200551935198
   PubMed Web of Science ®Google Scholar
• C.Conry-CantilenaHepatitis C virus diagnostics: technology, clinical applications and impactsTrends Biotech15219977176
   Web of Science ®Google Scholar
• A.BonioloM.DavisR.MathezaThe use of ELISA in screening of HBsAgJ Immunol19824954
   Google Scholar
• S.KumarD.C.PoundSerological diagnosis of viral hepatitisPostgrad Med92419925565
   Web of Science ®Google Scholar
• P.TangkijvanichT.ChanmeeS.KomtongV.MahachaiN.WisedopasP.PothacharoenDiagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancersJ gastroenterol hepatol2512010129137
   PubMed Web of Science ®Google Scholar
• J.F.PerzG.L.ArmstrongL.A.FarringtonY.J.HutinB.P.BellThe contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJ Hepatol45200629538
   Web of Science ®Google Scholar
• E.P.DiamandisB.R.HoffmanC.M.SturgeonNational academy of clinical biochemistry laboratory medicine practice guidelines for the use of tumor markersClin Chem5411200819351939
   Web of Science ®Google Scholar
• D.PoonB.O.AndersonL.T.ChenK.TanakaW.Y.LauE.Van CutsemManagement of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009Lancet Oncol10200911111118
   PubMed Web of Science ®Google Scholar
• J.FilmusH.SongW.ShiA.Duenas GonzalezM.KayaD.Cano-GauciGlypican-3 is a novel inhibitor of insulin-like growth factor signalingMedicina (B Aires)591999546
   Web of Science ®Google Scholar
• H.TakaiM.AshiharaT.IshiguroH.TerashimaT.WatanabeA.KatoInvolvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinomaCancer Biol Ther8200923292338
   PubMed Web of Science ®Google Scholar
• N.I.ZakharyM.S.MohamedO.KhorshidR.S.AzerN.ZayedRole of glypican-3 in the early diagnosis of hepatocellular carcinoma among Egyptian patientsJ Genetic Engineer Biotechnol1020127379
   Google Scholar
• M.CapurroI.R.WanlessM.ShermanG.DeboerW.ShiE.MiyoshiGlypican-3: a novel serum and histochemical marker for hepatocellular carcinomaGastroenterology12520038190
   Web of Science ®Google Scholar
• N.YamauchiA.WatanabeM.HishinumaK.OhashiY.MidorikawaY.MorishitaThe glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinomaMod Pathol18200515911598
   PubMed Web of Science ®Google Scholar
• A.I.GomaaO.M.HendyG.Y.Abou RaiaH.AttiaH.M.ElezawyE.NafieThe diagnostic value of peripheral blood glypican-3 in patients with hepatocellular carcinomaWorld J Med Sci722012105112
   Google Scholar
• S.S.QiaoZ.Q.CuiL.GongH.HanP.C.ChenL.M.GuoSimultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinomaHepatogastroenterology58110–111201117181724
   Google Scholar
• N.ShafizadehL.D.FerrellS.KakarUtility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrumModern Pathol21200810111018
   PubMed Web of Science ®Google Scholar
• J.BruixM.ShermanManagement of hepatocellular carcinoma:an updateHepatology53201110201022
   PubMed Web of Science ®Google Scholar
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol562012908943
   PubMed Web of Science ®Google Scholar
• E.YasudaT.KumadaH.ToyodaY.KaneokaA.MaedaS.OkudaEvaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinomaHepatol Res4052010477485
   Web of Science ®Google Scholar
• H.OzkanH.ErdalE.KoçakH.TutkakZ.KaraerenM.YakutDiagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinomaJ Clin Lab Anal2552011350353
   Web of Science ®Google Scholar
• T.NakatsuraY.YoshitakeS.SenjuM.MonjiH.KomoriY.MotomuraGlypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor markerBiochem Biophys Res Commun306120031625
   PubMed Web of Science ®Google Scholar
• D.KandilG.LeimanM.AllegrettaW.TrotmanL.PantanowitzR.GoulartGlypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesionsCancer11152007316322
   Web of Science ®Google Scholar
• T.NakatsuraT.KageshitaS.ItoK.WakamatsuM.MonjiY.IkutaIdentification of glypican-3 as a novel tumor marker for melanomaClin Cancer Res1019200466126621
   Web of Science ®Google Scholar
• S.StadlmannU.GuethD.BaumhoerH.MochL.TerraccianoG.SingerGlypican-3 expression in primary and recurrent ovarian carcinomasInt J Gynecol Pathol2632007341344
   Web of Science ®Google Scholar
• T.MounajjedL.ZhangT.T.WuGlypican-3 expression in gastrointestinal and pancreatic epithelial neoplasmsHum Pathol4442013542550
   Web of Science ®Google Scholar